Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Drug Deliv Transl Res. 2021 Mar 12;11(4):1675–1688. doi: 10.1007/s13346-021-00955-0

Table 2.

Summary of vascular stent technologies approved for clinical use.

Device Implant Manufacturer Material Active agent Reference(s)
Bare metal stents Vision Abbott Cobalt-Chromium None [126,127]
Rebel Boston scientific Platinum-Chromium None
Integrity Medtronic Cobalt-Chromium None
Drug eluting stents TAXUS Boston scientific Stainless steel, SIBS. Paclitaxel [135.136.137.138]
Cypher J&J Stainless steel, PBMA/PEVA. Sirolimus
Xience Abbott Cobalt-Chromium, PBMA/PVDF-HFP. Everolimus
Promus Boston scientific Platinum-Chromium, PBMA/PVDF-HFP. Everolimus
Endeavor Medtronic Cobalt-Chromium, Phosphoryl choline. Zotarolimus
Resolute Medtronic Cobalt-Chromium, biolynx. Zotarolimus
JANUS Sorin biomedica Cobalt-Chromium-Carbofilm. Tacrolimus
Bioabsorbable vascular scaffolds ABSORB Abbott PLLA, PDLLA Everolimus [127]
Synergy Boston scientific Platimun-Chromium, PLGA Everolimus
Orsiro Biotronik Cobalt-Chromium, PLLA Sirolimus
Endothelial cell capture stents Genous OrbusNiech medical technologies Stainless steel, Polysaccharide coating CD34+ antibody [139.140]
COMBO Stainless steel, ULG CD34 + antibody coating Sirolimus, CD34+antibody